000 01383 a2200373 4500
005 20250517020129.0
264 0 _c20160414
008 201604s 0 0 eng d
022 _a1938-0682
024 7 _a10.1016/j.clgc.2015.01.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Dodewaard-de Jong, Joyce M
245 0 0 _aNew Treatment Options for Patients With Metastatic Prostate Cancer: What Is The Optimal Sequence?
_h[electronic resource]
260 _bClinical genitourinary cancer
_cAug 2015
300 _a271-279 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xpharmacology
650 0 4 _aBone Neoplasms
_xsecondary
650 0 4 _aClinical Trials as Topic
650 0 4 _aCombined Modality Therapy
650 0 4 _aDrug Administration Schedule
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
_xpathology
650 0 4 _aRadiopharmaceuticals
_xtherapeutic use
700 1 _aVerheul, Henk M W
700 1 _aBloemendal, Haiko J
700 1 _ade Klerk, John M H
700 1 _aCarducci, Michael A
700 1 _avan den Eertwegh, Alfons J M
773 0 _tClinical genitourinary cancer
_gvol. 13
_gno. 4
_gp. 271-279
856 4 0 _uhttps://doi.org/10.1016/j.clgc.2015.01.008
_zAvailable from publisher's website
999 _c24644947
_d24644947